Panacea
Panacea is a YC Spring 2026 (P26) company. Based in San Francisco, CA, USA. Team of 2.
About Panacea
Summary
Panacea delivers FDA regulatory services to biotech and medical device companies, pairing ex-FDA consultants with a proprietary AI platform to prepare and submit filings across pathways including 510(k), De Novo, PMA, IND, NDA, and BLA. It replaces traditional regulatory consulting firms, whose hourly billing and slower turnaround create bottlenecks on the path to approval.
Business model
Fixed, milestone-based fees due only when defined milestones are complete.
Go-to-market
Biotech and medical device companies engage Panacea directly, starting with a free consultation to scope their regulatory pathway.
From the Y Combinator listing
AI-Native FDA Regulatory Services
Panacea provides AI-native FDA regulatory services for Biotechs and Medical Device companies. We hire the most experienced FDA consultants in the industry (ex-FDA, decades of experience, hundreds of filings) and pair them with our AI platform to enable the fastest and lowest cost pathway to FDA approval. While other regulatory consultants bill hourly, our pricing model is simple: fixed, outcome-based pricing. Payment is only due when milestones are complete. We support all FDA regulatory pathways including IND, NDA, BLA, ODD, Pre-Subs, 510(k), De Novo, PMA, IDE, BDD, etc.
Facts
- Healthcare / Healthcare -> Healthcare Services
- San Francisco, CA, USA
- 2
- Active
- Early
Founders (2)
- Haris Javed-Akhtar
- Yaman Ziadeh
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works